Published in AIDS Weekly, December 18th, 2000
The company also announced the publication of a scientific article describing the results of a previous Phase I/II clinical trial of PRO 542 in HIV infected children, including those resistant to available antiviral therapies. The article appeared in the December 2000 issue of The Journal of Infectious Diseases (vol. 182, no. 6).
The goal of the initiated Phase II trial is to define the dose and frequency of administration of PRO...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.